Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ultralife (ULBI) Net Income towards Common Stockholders (2016 - 2025)

Ultralife has reported Net Income towards Common Stockholders over the past 16 years, most recently at -$4.9 million for Q4 2025.

  • Quarterly results put Net Income towards Common Stockholders at -$4.9 million for Q4 2025, up 11.85% from a year ago — trailing twelve months through Dec 2025 was -$3.4 million (down 672.19% YoY), and the annual figure for FY2025 was -$3.4 million, down 672.19%.
  • Net Income towards Common Stockholders for Q4 2025 was -$4.9 million at Ultralife, down from -$1.2 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for ULBI hit a ceiling of $3.3 million in Q2 2023 and a floor of -$5.6 million in Q4 2024.
  • Median Net Income towards Common Stockholders over the past 5 years was $508000.0 (2022), compared with a mean of $231789.5.
  • Biggest five-year swings in Net Income towards Common Stockholders: skyrocketed 966.87% in 2024 and later plummeted 546.95% in 2025.
  • Ultralife's Net Income towards Common Stockholders stood at -$424000.0 in 2021, then skyrocketed by 42.92% to -$242000.0 in 2022, then surged by 1061.98% to $2.3 million in 2023, then tumbled by 339.65% to -$5.6 million in 2024, then grew by 11.85% to -$4.9 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$4.9 million (Q4 2025), -$1.2 million (Q3 2025), and $870000.0 (Q2 2025) per Business Quant data.